GVHD: Clinical Trials

4 trials for GVHD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 21Completed 1

Follow GVHD: new trials by email Literature Review of GVHD trials Research Report on GVHD

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of PMSCs and Their Secretome for the Treatment of GvHD
Secretome (set of substances released from the cell to its surroundings) of mesenchymal stem cells retrieved from the placenta (containing 400 microgram protein/ milliliter), 4 cc distilled water dissolved in albumin 20% - GVHD
Phase 3CompletedTabriz University of Medical Sciences602023-01-012024-06-21
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
CD45RA-depleted peripheral blood mononuclear cells - Leukemia, Lymphoma
Phase 2 / Phase 3CompletedFederal Research Institute of Pediatric Hematology, Oncology and Immunology1502016-10-012023-03-16
Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC)
Spectra Optia - GvHD, Lung Graft Dysfunction
Phase 3CompletedFondazione IRCCS Policlinico San Matteo di Pavia512015-08-012016-01-11
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
US-ATG-F, Placebo - GVHD, Adult Acute Myeloid Leukemia
Phase 3CompletedNeovii Biotech2602011-10-102019-04-09

Narrower conditions

Graft vs Host Disease (2)  ·  Myelodysplastic Syndromes (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)  ·  Opportunistic Infections (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Immune System Diseases (3)  ·  Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Infections (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)

Interventions

Secretome (1)

Sponsors

Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Neovii Biotech (1)  ·  Tabriz University of Medical Sciences (1)

Countries

Australia (1)  ·  Iran (1)  ·  Italy (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Anne Kuan (1)  ·  Babak Nejati, MD (1)  ·  Graciela Pavon-Djavid, PhD (1)  ·  Hossein Ghasemi Moghadam, MD (1)  ·  Larisa Shelikhova, PhD (1)  ·  Michael Maschan, PhD (1)  ·  Sepideh Zununi Vahed, PhD (1)

Results publications

PMID 37341189